Abstract
The study of hereditary RCC syndromes continues to provide significant insight into the pathways that are involved in renal cell tumorigenesis. The clinician should maintain a high level of suspicion for genetic disorders when patients present with early-onset or mult-focal RCC. Recognition of familial syndromes will facilitate the institution of parenchymal sparing measures, as well as appropriate screening and intervention for associated nonrenal manifestations.
MeSH terms
-
Carcinoma, Renal Cell / genetics*
-
Carcinoma, Renal Cell / pathology
-
Genes, Dominant
-
Genetic Linkage
-
Genetic Predisposition to Disease*
-
Humans
-
Kidney Neoplasms / genetics*
-
Kidney Neoplasms / pathology
-
Ligases / genetics
-
Syndrome
-
Tumor Suppressor Proteins*
-
Ubiquitin-Protein Ligases*
-
Von Hippel-Lindau Tumor Suppressor Protein
-
von Hippel-Lindau Disease / genetics
Substances
-
Tumor Suppressor Proteins
-
Ubiquitin-Protein Ligases
-
Von Hippel-Lindau Tumor Suppressor Protein
-
Ligases
-
VHL protein, human